Mirae Asset recruits OneVentures director for Australia coverage
Mirae Asset Global Investments has expanded its Australian alternatives team with the recruitment of James McGrath, formerly an investment director at local VC firm OneVentures.
McGrath spent six years at OneVentures, which backs emerging Australian technology and healthcare companies. He held board observer positions at Ovo Mobile, Coassemble, Fleet Space Technologies, EatClub,...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.